Yüklüyor......
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
Background: Chemotherapy is currently evaluated in order to enhance the efficacy of immune checkpoint blockade (ICB) therapy in colorectal cancer. However, the mechanisms by which these drugs could synergize with ICB remains unclear. The impact of chemotherapy on the PD-1/PD-L1 pathway and the resul...
Kaydedildi:
| Yayımlandı: | Oncoimmunology |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980491/ https://ncbi.nlm.nih.gov/pubmed/29872568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1433981 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|